Specific binding of luteinizing hormone releasing hormone to human luteal tissue
- PMID: 6309178
- DOI: 10.1016/0006-291x(83)90844-6
Specific binding of luteinizing hormone releasing hormone to human luteal tissue
Abstract
Homogenates of human luteal tissue bound radioiodinated luteinizing hormone releasing hormone agonist. Specific binding was both time- and temperature-dependent. Native LHRH and two LHRH agonists competed for binding, whereas TRH, somatostatin and oxytocin did not, indicating that the binding sites were specific. The apparent Ka values were 2 X 10(7)M-1 for both LHRH agonists and 10(6)M-1 for native LHRH. This is the first demonstration of specific binding of LHRH to human ovarian tissue. No binding could be detected to ovarian tissue from postmenopausal women.
Similar articles
-
Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin.J Clin Endocrinol Metab. 1984 Jul;59(1):119-26. doi: 10.1210/jcem-59-1-119. J Clin Endocrinol Metab. 1984. PMID: 6327754
-
Specific binding of gonadotrophin-releasing hormone and an agonist to human corpus luteum homogenates: characterization, properties, and luteal phase levels.J Clin Endocrinol Metab. 1985 Nov;61(5):834-41. doi: 10.1210/jcem-61-5-834. J Clin Endocrinol Metab. 1985. PMID: 3930550
-
D-Ala6-des-Gly10-gonadotropin-releasing hormone ethylamide: absence of binding sites and lack of a direct effect in rabbit corpora lutea.Biol Reprod. 1985 Mar;32(2):226-31. doi: 10.1095/biolreprod32.2.226. Biol Reprod. 1985. PMID: 2985133
-
Contraception with LHRH agonists, a new physiological approach.Reproduccion. 1981 Oct-Dec;5(4):229-41. Reproduccion. 1981. PMID: 6274723 Review.
-
Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.Prog Clin Biol Res. 1981;74:273-91. Prog Clin Biol Res. 1981. PMID: 6275404 Review.
Cited by
-
LRFD6a has a dose-related stimulatory or inhibitory effect on the ovary in normal luteal phase women.J Endocrinol Invest. 1985 Aug;8(4):297-302. doi: 10.1007/BF03348501. J Endocrinol Invest. 1985. PMID: 3934254
-
GnRH and its analogues. Current therapeutic applications and new prospects.Drugs. 1984 Mar;27(3):187-93. doi: 10.2165/00003495-198427030-00001. Drugs. 1984. PMID: 6368183 Review. No abstract available.
-
The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).J In Vitro Fert Embryo Transf. 1991 Oct;8(5):254-9. doi: 10.1007/BF01139780. J In Vitro Fert Embryo Transf. 1991. PMID: 1836810 Clinical Trial.
-
Spatial proteomics: a powerful discovery tool for cell biology.Nat Rev Mol Cell Biol. 2019 May;20(5):285-302. doi: 10.1038/s41580-018-0094-y. Nat Rev Mol Cell Biol. 2019. PMID: 30659282 Review.
-
Analysis of implantation in assisted reproduction through the use of serial human chorionic gonadotropin measurements.J Assist Reprod Genet. 1998 Sep;15(8):496-503. doi: 10.1023/a:1022534521019. J Assist Reprod Genet. 1998. PMID: 9785197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources